HUREL Micro Liver Overview Webinar
Carol Tomaszewski2021-11-05T15:33:34-05:00Visikol's CEO Michael Johnson, Ph.D. gives an overview of Visikol's HUREL Micro Liver products and services. [...]
HUREL Models Assist in the Evaluation of Hepatoxicity
Carol Tomaszewski2021-10-25T09:07:40-05:00Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]
HUREL Model Micro Livers and Hepatitis B
Carol Tomaszewski2022-10-17T12:55:13-05:00While hepatitis B infection is preventable by a well-established vaccine, the disease has proven to be [...]
HUREL Products and Services Are Now Part of Visikol
Carol Tomaszewski2021-10-14T13:28:06-05:00BICO has acquired HUREL micro liver technologies to offer the market's most comprehensive liver in vitro services BICO, leading [...]